Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Immune checkpoint inhibitors in liver transplant: a case series.
Journal: Journal of gastrointestinal oncology
Published: September 22, 2022
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Journal: Nature medicine
Published: August 25, 2022
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.
Journal: Blood advances
Published: March 04, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.
Journal: Blood cancer discovery
Published: January 21, 2022
COVID-19 vaccination and breakthrough infections in patients with cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 21, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Journal: Blood advances
Published: March 01, 2021
Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer.
Journal: Pancreas
Published: July 14, 2020
Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
Journal: The Journal of surgical research
Published: December 01, 2019
Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer.
Journal: American journal of clinical oncology
Published: February 07, 2019
Last Updated: 09/26/2026